Triple

T6211321
Position Surface form Disambiguated ID Type / Status
Subject European Quarter of Strasbourg E138876 entity
Predicate hostsInstitution P186 FINISHED
Object European Directorate for the Quality of Medicines & HealthCare E12899 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Directorate for the Quality of Medicines & HealthCare | Statement: [European Quarter of Strasbourg, hostsInstitution, European Directorate for the Quality of Medicines & HealthCare]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Directorate for the Quality of Medicines & HealthCare
Context triple: [European Quarter of Strasbourg, hostsInstitution, European Directorate for the Quality of Medicines & HealthCare]
  • A. European Directorate for the Quality of Medicines & HealthCare chosen
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • B. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • D. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • E. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008ada364819096c9e92c74d639b5 completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c0628adccc8190b94f5c2c1d5d03f7 completed March 22, 2026, 9:43 p.m.
NED1 Entity disambiguation (via context triple) batch_69c16f57821c8190bd7a5f6bf286ab09 completed March 23, 2026, 4:50 p.m.
Created at: March 22, 2026, 4:21 p.m.